{"id":"W2965327853","doi":"10.1177/2047487319864671","title":"Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy","year":2019,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital","funders":"National Institutes of Health; Esperion Therapeutics; Ionis Pharmaceuticals; Mylan; National Institute for Health and Care Research; Medicines Company; Amarin Corporation; Sanofi; Kowa Company; Regeneron Pharmaceuticals; American Heart Association; Pfizer; Amgen; Abbott Diagnostics; European Atherosclerosis Society; Eli Lilly and Company","keywords":"Ezetimibe; Medicine; Internal medicine; Placebo; Statin; Clinical endpoint; Fixed-dose combination; Familial hypercholesterolemia; Combination therapy; Cholesterol; Gastroenterology; Endocrinology; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009484103,0.0005287054,0.002623795,0.0003286466,0.0002467675,0.0005311653,0.0003732581,0.0006239099,0.001535875],"category_scores_gemma":[0.0008164168,0.0003313339,0.0008472165,0.0003051711,0.0003341683,0.0004129158,0.0002252445,0.001026627,0.0002518422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003518994,"about_ca_system_score_gemma":0.0005549433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002935746,"about_ca_topic_score_gemma":0.001093608,"domain_scores_codex":[0.9994965,0.0002625889,0.00005920724,0.00005765771,0.00006494685,0.00005907695],"domain_scores_gemma":[0.9996865,0.00007451218,0.00008662701,0.00001700212,0.00001992984,0.0001154566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8419356,0.01504943,0.0153933,0.001159802,0.002870511,0.0003799045,0.0001297795,0.001059557,0.03526579,0.0001793147,0.0009210394,0.08565605],"study_design_scores_gemma":[0.5725805,0.3702028,0.04534639,0.0001498863,0.002639845,0.0006914372,0.000127319,0.001893284,0.003275657,0.0002487048,0.002792475,0.00005170663],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926812,0.005774241,0.0002654329,0.0002109304,0.00008391601,0.0002468273,0.00006913263,0.00002280735,0.0006454961],"genre_scores_gemma":[0.9961752,0.001756884,0.0008327315,0.0003752644,0.0001369285,0.0002275243,0.0001601907,0.000003563624,0.0003317778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002623795,"threshold_uncertainty_score":0.00513798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006406354205373587,"score_gpt":0.2084279197838719,"score_spread":0.2020215655784983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}